Endogenex today reported positive findings from studies of its endoscopic procedure aimed at transforming diabetes care.

Being part of both EAN and ATMRD gives us the opportunity to engage with the broader neurology community, while spotlighting a range of data on ND0612 across two key scientific forums,” said Gustavo A ...

Breakthrough Studies Demonstrate Stem Cell-Based Technologies as a Potential Alternative Treatment for Type 1 Diabetes CHICAGO, June 20, 20 ...

Verdiva Bio Limited ("Verdiva" or "the Company") a clinical-stage biopharmaceutical company focused on developing innovative ...